Clinical, Laboratory and Radiological Evaluation of Intensive Care Patients Who Developed COVID-19 Associated Pneumomediastinum

Abstract views: 229 / PDF downloads: 177




COVID-19, pneumomediastinum, mortality, Computed Tomography


Objective: This study aims to identify possible risk factors and clinical, laboratory, or radiological predictors for COVID-19 associated pneumomediastinum.

Methods: Patients who developed pneumomediastinum under mechanical ventilation (MV) due to COVID-19 pneumonia during intensive care unit (ICU) (Group 1), and patients who died without developing pneumomediastinum during ICU (Group 2) were compared statistically in terms of age, laboratory parameters, medical treatments, mechanical ventilator parameters, and radiological findings.

Results: Group 1 patients were significantly younger than Group 2 patients (p<0.05). There was no significant difference between groups in terms of laboratory parameters except N/L ratios and sedimentation rates (p>0.05). There was no significant difference between the groups in terms of dominant infiltration pattern, pleural and pericardial effusion (p>0.05). The incidence of organizing pneumonia pattern, and infiltration of more than 75% of the total lung parenchyma were significantly higher in Group 1 (p<0.01). The rates of favipiravir treatment, immunomodulatory therapy and prone positioning were significantly lower in Group 1 than Group 2 (p<0.01). There was no significant difference between groups in terms of the duration of ICU hospitalization and MV, PEEPmax, PIPmax and PaO2/FiO2 (p>0.05).

Conclusion: Care should be taken in terms of pneumomediastinum in patients who show diffuse organized pneumonia patterns affecting more than 75% of the parenchyma area.


Metrics Loading ...

Author Biography

Deniz Esin Sanli, Department of Radiology, Gaziantep University Faculty of Medicine




Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT, et al. (2021) SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA network open. 4(1):e2035057.

Fajgenbaum DC, June CH. (2020) Cytokine Storm. N Engl J Med. 383(23):2255-2273.

Luo M, Cao S, Wei L, Zhao X, Gao F, Li S, et al. (2020) Intubation, mortality, and risk factors in critically ill Covid-19 patients: A pilot study. J Clin Anesth. 67:110039.

Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. (2020) China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 55(5):2000547.

Elhakim TS, Abdul HS, Pelaez Romero C, Rodriguez-Fuentes Y. (2020) Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19 pneumonia: a rare case and literature review. BMJ Case Rep. 13(12):e239489.

Kangas-Dick A, Gazivoda V, Ibrahim M, Sun A, Shaw JP, Brichkov I, et al. (2021) Clinical Characteristics and Outcome of Pneumomediastinum in Patients with COVID-19 Pneumonia. J Laparoendosc Adv Surg Tech A. 31(3):273-278.

Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. (2020) Radiological Society of North America Expert Consensus Document on Reporting Chest CT Findings Related to COVID-19: Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging. 2(2):e200152.

Pogatchnik BP, Swenson KE, Sharifi H, Bedi H, Berry GJ, Guo HH. (2020) Radiology-Pathology Correlation Demonstrating Organizing Pneumonia in a Patient Who Recovered from COVID-19. Am J Respir Crit Care Med. 202(4):598-599.

Tekcan Sanli DE, Yildirim D, Sanli AN, Erozan N, Husmen G, Altundag A, et al. (2021) Predictive value of CT imaging findings in COVID-19 pneumonia at the time of first-screen regarding the need for hospitalization or intensive care unit. Diagn Interv Radiol. 27(5):599-606.

Simsek EE, Guner AE, Kul S, Karakurt Z, Tekesin K, Birinci S. (2020) A comparative analysis of the COVID-19 pandemic response: The case of Turkey. North Clin Istanb. 7(5):443-451.

Jordan RE, Adab P, Cheng KK. (2020) Covid-19: risk factors for severe disease and death. BMJ. 368:m1198.

Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, et al. (2020) Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan’s Experience. Anesthesiology. 132(6):1317-1332.

Ghani M, Rodriguez-Ortiz Y, Ahmad D, Pham J, Tamsukhin P, Mir P. (2020) Spontaneous pneumomediastinum in patients with SARS-Cov-2 virus (COVID-19). Chest. 158(4):A1231-2.

Kolani S, Houari N, Haloua M, Alaoui Lamrani Y, Boubbou M, Serraj M, et al. (2020) Spontaneous pneumomediastinum occurring in the SARS-COV-2 infection. IDCases. 21:e00806.

Anzueto A, Frutos-Vivar F, Esteban A, Alía I, Brochard L, Stewart T, et al. (2004) Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients. Intensive Care Med. 30(4):612-9.

McGuinness G, Zhan C, Rosenberg N, Azour L, Wickstrom M, Mason DM, Thomas KM, Moore WH. (2020) Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation. Radiology. 297(2):E252-E262.

Wali A, Rizzo V, Bille A, Routledge T, Chambers AJ. (2020) Pneumomediastinum following intubation in COVID-19 patients: a case series. Anaesthesia. 75(8):1076-1081.

Sanli DET, Altundag A, Kandemirli SG, Yildirim D, Sanli AN, Saatci O, et al. (2021) Relationship between disease severity and serum IL-6 levels in COVID-19 anosmia. Am J Otolaryngol. 42(1):102796.

Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. (2020) Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta. 510:475-482.

de Oliveira Filho CM, Vieceli T, de Fraga Bassotto C, da Rosa Barbato JP, Garcia TS, Scheffel RS. (2021) Organizing pneumonia: A late phase complication of COVID-19 responding dramatically to corticosteroids. Braz J Infect Dis. 25(1):101541.

Kory P, Kanne JP. (2020) SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’. BMJ Open Respir Res. 7(1):e000724.

Manabe T, Kambayashi D, Akatsu H, Kudo K. (2021) Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 21(1):489.

Zhao M. (2020) Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies. Int J Antimicrob Agents. 55(6):105982.

Alijotas-Reig J, Esteve-Valverde E, Belizna C, Selva-O’Callaghan A, Pardos-Gea J, Quintana A, et al. (2020) Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmun Rev. 19(7):102569.

van der Veer T, van der Sar-van der Brugge S, Paats MS, van Nood E, de Backer IC, Aerts JGJV, et al. (2021) Do-not-intubate status and COVID-19 mortality in patients admitted to Dutch non-ICU wards. Eur J Clin Microbiol Infect Dis. 40(10):2207-2209.

Zirpe KG, Tiwari AM, Gurav SK, Deshmukh AM, Suryawanshi PB, Wankhede PP, et al. (2021) Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome. Indian J Crit Care Med. 25(5):493-498.




How to Cite

Sanli, D. E., Gulek, E., Erozan, N., Kurtcan, S., Dikmen, I., Sanli, A. N., Kirisoglu, C. E., Yildirim, D., Dikensoy, O., & Akinci, I. O. (2023). Clinical, Laboratory and Radiological Evaluation of Intensive Care Patients Who Developed COVID-19 Associated Pneumomediastinum . European Journal of Therapeutics, 29(3), 284–297.



Original Articles